Universe Pharmaceuticals (UPC) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to -$3573.1 billion.
- Universe Pharmaceuticals' Accumulated Depreciation & Amortization fell 42.86% to -$3573.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3573.1 billion, marking a year-over-year decrease of 42.86%. This contributed to the annual value of -$3573.1 billion for FY2025, which is 42.86% down from last year.
- According to the latest figures from Q3 2025, Universe Pharmaceuticals' Accumulated Depreciation & Amortization is -$3573.1 billion, which was down 42.86% from -$3557.8 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $6.1 million during Q3 2023, with a 5-year trough of -$3573.1 billion in Q3 2025.
- Its 5-year average for Accumulated Depreciation & Amortization is -$1426.2 billion, with a median of $5.7 million in 2022.
- In the last 5 years, Universe Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 10000.01% in 2021 and then plummeted by 5880233031.89% in 2024.
- Universe Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $5.8 million in 2021, then dropped by 1.21% to $5.7 million in 2022, then increased by 5.96% to $6.1 million in 2023, then tumbled by 58802330.32% to -$3557.8 billion in 2024, then decreased by 0.43% to -$3573.1 billion in 2025.
- Its Accumulated Depreciation & Amortization stands at -$3573.1 billion for Q3 2025, versus -$3557.8 billion for Q3 2024 and $6.1 million for Q3 2023.